Pancreas Formula

Adenosine Triphosphate, Tribasic Calcium Phosphate, Cinchona Officinalis Bark, Saffron, Phosphorus, Viscum Album Fruiting Top


Apex Energetics Inc.
Human Otc Drug
NDC 63479-2503
Pancreas Formula also known as Adenosine Triphosphate, Tribasic Calcium Phosphate, Cinchona Officinalis Bark, Saffron, Phosphorus, Viscum Album Fruiting Top is a human otc drug labeled by 'Apex Energetics Inc.'. National Drug Code (NDC) number for Pancreas Formula is 63479-2503. This drug is available in dosage form of Solution/ Drops. The names of the active, medicinal ingredients in Pancreas Formula drug includes Adenosine Triphosphate - 5 [hp_X]/mL Cinchona Officinalis Bark - 7 [hp_C]/mL Phosphorus - 30 [hp_C]/mL Saffron - 2 [hp_Q]/mL Tribasic Calcium Phosphate - 1 [hp_Q]/mL Viscum Album Fruiting Top - 7 [hp_C]/mL . The currest status of Pancreas Formula drug is Active.

Drug Information:

Drug NDC: 63479-2503
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Pancreas Formula
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Adenosine Triphosphate, Tribasic Calcium Phosphate, Cinchona Officinalis Bark, Saffron, Phosphorus, Viscum Album Fruiting Top
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Apex Energetics Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Solution/ Drops
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ADENOSINE TRIPHOSPHATE - 5 [hp_X]/mL
CINCHONA OFFICINALIS BARK - 7 [hp_C]/mL
PHOSPHORUS - 30 [hp_C]/mL
SAFFRON - 2 [hp_Q]/mL
TRIBASIC CALCIUM PHOSPHATE - 1 [hp_Q]/mL
VISCUM ALBUM FRUITING TOP - 7 [hp_C]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:SUBLINGUAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 22 Mar, 2022
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 06 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Apex Energetics Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:8L70Q75FXE
S003A158SB
27YLU75U4W
E849G4X5YJ
91D9GV0Z28
BK9092J5MP
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
63479-2503-11 mL in 1 BOTTLE, GLASS (63479-2503-1)22 Mar, 2022N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

For temporary relief of minor: bloating* indigestion* sweet cravings* tiredness after meals* loose stool* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Product Elements:

Pancreas formula adenosine triphosphate, tribasic calcium phosphate, cinchona officinalis bark, saffron, phosphorus, viscum album fruiting top adenosine triphosphate adenosine triphosphate water saffron saffron tribasic calcium phosphate phosphate ion viscum album fruiting top viscum album fruiting top cinchona officinalis bark cinchona officinalis bark alcohol phosphorus phosphorus

Indications and Usage:

Uses: for temporary relief of minor: bloating* indigestion* sweet cravings* tiredness after meals* loose stool* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Warnings:

Warnings: if pregnant or breastfeeding , ask a health professional before use. do not use if clear seal over the cap is broken or missing. keep out of reach of children. in case of overdose, get medical help or contact a poison control center right away. stop use and ask a doctor if bloating, indigestion, sweet cravings, tiredness after meals, loose stool, or other symptoms do not improve within 7 days or are accompanied by fever.

Dosage and Administration:

Directions: adults & children ages 12 years and over: take 10 drops under the tongue 3 times a day, or as directed by your healthcare professional. consult a physician for use in children under 12 years of age.

Stop Use:

Stop use and ask a doctor if bloating, indigestion, sweet cravings, tiredness after meals, loose stool, or other symptoms do not improve within 7 days or are accompanied by fever.

Package Label Principal Display Panel:

The younger you® dr. galitzer’s pancreas formula bloating* indigestion* sweet cravings* homeopathic formula 1 fl oz (30 ml) alcohol 20% by volume yyr03-220224

Further Questions:

Distributed by apex energetics. questions? 16592 hale ave., irvine, ca 92606, usa


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.